Biotechnologie 23 Srpen 2025 - 29 Leden 2026

U.S. senators move to police synthetic DNA sales as bioweapon fears sharpen

Američtí senátoři chtějí regulovat prodej syntetické DNA kvůli rostoucím obavám z biologických zbraní

Two U.S. senators introduced a bill requiring the Commerce Department to regulate synthetic DNA sales and mandate customer screening for dangerous genetic sequences. The proposal orders a federal list of “sequences of concern,” compliance audits, and civil penalties up to $750,000. It also calls for a NIST “governance sandbox” and federal oversight review of biosecurity.
5 února, 2026
Neuron Xenotransplantation

Prasečí neurony v lidském mozku? Realita roku 2025 v xenotransplantaci neuronů—průlomy, rizika a co nás čeká dál

The FDA approved the first clinical trials of kidney xenotransplantation in 2024. Preclinical studies show pig neuron precursors can function in rodents and marine mammals, while human neurons integrate in animal brains for research. No neuron xenotransplants have been performed in patients. Advances in gene editing and immune protection have improved safety for all xenotransplantation.
23 září, 2025
Groundbreaking treatments - super crops - and a revolution in green technology

Biotechnologie 2025: Průlomové léky, superplodiny a revoluce zelených technologií

The global biotechnology market is projected to grow from $483 billion in 2024 to $546 billion in 2025, a 13% increase. Casgevy gene therapy for sickle cell disease and beta-thalassemia is expected to reach patients in 2025. Novo Nordisk and Eli Lilly are investing billions to address U.S. shortages of GLP-1 drugs. Over 60% of new crop varieties in 2025 use CRISPR technology.
23 srpna, 2025